Solara Active Pharma Sciences Ltd

Solara Active Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Solara Active Pharma Sciences Ltd

₹ 552 16.45%
19 Apr - close price
solara.co.in BSE: 541540 NSE : SOLARA
About

Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs.[1]

It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.[2]

Key Points

Business Segments
It is a global, R&D-focused, pure-play Active Pharmaceutical Ingredients (API) company engaged in the manufacturing and development of APIs and offering Contract Manufacturing and Development Services for global companies. [1]

Website BSE NSE
  • Market Cap ₹ 1,986 Cr.
  • Current Price ₹ 552
  • High / Low ₹ 564 / 286
  • Stock P/E
  • Book Value ₹ 408
  • Dividend Yield 0.00 %
  • ROCE 1.80 %
  • ROE -1.44 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 30.5%
  • Company has a low return on equity of 3.24% over last 3 years.
  • Promoters have pledged 48.0% of their holding.
  • Promoter holding has decreased over last 3 years: -13.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
427 444 406 402 100 361 330 338 395 381 352 425 249
322 345 314 329 197 348 320 311 349 329 333 388 410
Operating Profit 105 100 92 72 -97 13 10 28 45 52 19 38 -162
OPM % 25% 22% 23% 18% -96% 4% 3% 8% 11% 14% 5% 9% -65%
8 10 5 3 3 3 6 4 7 5 2 -2 -62
Interest 20 25 19 17 18 21 22 22 24 22 26 24 25
Depreciation 27 27 28 28 28 28 28 29 28 26 26 26 26
Profit before tax 66 57 51 30 -140 -33 -34 -19 1 8 -30 -15 -275
Tax % 0% 0% 0% 0% 0% 101% 44% 48% 21% 22% 34% 0% 0%
66 57 51 30 -140 0 -19 -10 0 6 -20 -15 -275
EPS in Rs 18.32 15.91 14.07 8.41 -38.83 0.06 -5.33 -2.75 0.12 1.79 -5.52 -4.24 -76.49
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
521 1,387 1,322 1,617 1,268 1,444 1,407
462 1,173 1,065 1,232 1,187 1,309 1,460
Operating Profit 59 214 257 385 81 134 -53
OPM % 11% 15% 19% 24% 6% 9% -4%
2 12 27 28 14 22 -57
Interest 25 82 78 84 75 90 97
Depreciation 34 83 94 108 112 111 104
Profit before tax 2 61 112 221 -92 -45 -312
Tax % 0% 3% 0% 0% 36% 50%
2 59 112 221 -59 -22 -304
EPS in Rs 22.76 41.89 61.50 -16.27 -6.17 -84.46
Dividend Payout % 0% 22% 5% 11% 0% -49%
Compounded Sales Growth
10 Years: %
5 Years: 23%
3 Years: 3%
TTM: -1%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -776%
Stock Price CAGR
10 Years: %
5 Years: 6%
3 Years: -28%
1 Year: 51%
Return on Equity
10 Years: %
5 Years: 5%
3 Years: 3%
Last Year: -1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 25 26 27 36 36 36 36
Reserves 745 937 1,064 1,557 1,491 1,467 1,432
633 538 722 621 1,037 1,013 985
414 456 339 397 373 379 419
Total Liabilities 1,817 1,957 2,152 2,610 2,937 2,895 2,872
1,063 1,195 1,374 1,359 1,334 1,342 1,306
CWIP 70 39 40 88 239 238 250
Investments 19 18 18 18 15 16 15
666 705 719 1,145 1,350 1,298 1,301
Total Assets 1,817 1,957 2,152 2,610 2,937 2,895 2,872

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
50 166 242 154 -242 156
-85 -113 -359 -105 -243 -81
67 -23 97 92 334 -113
Net Cash Flow 32 30 -20 142 -151 -38

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 185 76 63 109 141 136
Inventory Days 252 111 170 149 321 258
Days Payable 420 126 131 154 150 139
Cash Conversion Cycle 17 62 102 104 312 256
Working Capital Days 112 36 68 119 253 216
ROCE % 10% 12% 15% -1% 2%

Shareholding Pattern

Numbers in percentages

14 Recently
Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
41.07% 41.07% 39.51% 39.71% 40.40% 40.41% 40.41% 40.98% 39.31% 37.19% 30.49% 30.49%
16.60% 17.28% 18.15% 19.42% 17.93% 18.47% 19.26% 19.30% 18.71% 17.86% 16.62% 15.80%
6.41% 6.05% 5.40% 3.64% 3.10% 2.97% 3.01% 2.75% 1.75% 1.79% 1.75% 2.97%
35.92% 35.60% 36.94% 37.22% 38.57% 38.16% 37.32% 36.95% 40.22% 43.16% 51.14% 50.73%
No. of Shareholders 67,19765,44973,00077,22882,71083,31979,14976,32575,41774,47372,91873,912

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls